Ken Fisher Agenus Inc Transaction History

Fisher Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$2.53 - $3.04 $28,477 - $34,218	-11,256 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$1.59 - $2.66 $318 - $532	-200 Reduced 1.75%	11,256 $27,000
Q3 2018 Oct 24, 2018	BUY	$1.59 - $2.42 $725 - $1,103	456 Added 4.15%	11,456 $25,000
Q2 2018 Jul 09, 2018	SELL	$2.26 - $4.65 $583,464 - $1.2 Million	-258,170 Reduced 95.91%	11,000 $25,000
Q1 2018 May 11, 2018	SELL	$3.51 - $6.04 $386,229 - $664,623	-110,037 Reduced 29.02%	269,170 $1.27 Million
Q1 2018 Apr 19, 2018	BUY	$3.51 - $6.04 $424,839 - $731,063	121,037 Added 46.88%	379,207 $1.79 Million
Q4 2017 Jan 24, 2018	BUY	$3.26 - $4.78 $212,780 - $311,990	65,270 Added 33.84%	258,170 $842,000
Q3 2017 Oct 17, 2017	BUY	$3.48 - $4.44 $671,292 - $856,476	192,900	192,900 $851,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.